Literature DB >> 24216135

The behavioral effects of acute Δ⁹-tetrahydrocannabinol and heroin (diacetylmorphine) exposure in adult zebrafish.

Adam Michael Stewart1, Allan V Kalueff2.   

Abstract

The use of psychotropic drugs in clinical and translational brain research continues to grow, and the need for novel experimental models and screens is becoming widely recognized. Mounting evidence supports the utility of zebrafish (Danio rerio) for studying various pharmacological manipulations, as an alternative model complementing the existing rodent paradigms in this field. Here, we explore the effects of acute 20-min exposure to two commonly abused psychotropic compounds, Δ(9)-tetrahydrocannabinol (THC) and heroin, on adult zebrafish behavior in the novel tank test. Overall, THC administration (30 and 50 mg/L) produces an anxiogenic-like reduction of top swimming, paralleled with a slower, continuous bottom swimming. In contrast, heroin exposure (15 and 25 mg/L) evoked a hyperlocomotor response (with rapid bouts of bottom swimming and frequent 'bouncing' motions) without altering anxiety-sensitive top/bottom endpoints. The behavioral effects of these two compounds in zebrafish seem to parallel the respective rodent and human findings. Collectively, this emphasizes the growing significance of novel emerging aquatic models in translational drug abuse research and small molecule screening.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety behavior; Cannabinoids; Heroin; Marijuana; Novel tank locomotion; Opioids; Psychotropic drugs; Zebrafish

Mesh:

Substances:

Year:  2013        PMID: 24216135     DOI: 10.1016/j.brainres.2013.11.002

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

Review 1.  Elucidating cannabinoid biology in zebrafish (Danio rerio).

Authors:  Randall G Krug; Karl J Clark
Journal:  Gene       Date:  2015-07-17       Impact factor: 3.688

Review 2.  Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model.

Authors:  Francesca Oltrabella; Adam Melgoza; Brian Nguyen; Su Guo
Journal:  Dev Growth Differ       Date:  2017-05-17       Impact factor: 2.053

3.  Concentration, population, and context-dependent effects of AM251 in zebrafish.

Authors:  Steven Tran; Diptendu Chatterjee; Amanda Facciol; Robert Gerlai
Journal:  Psychopharmacology (Berl)       Date:  2016-02-16       Impact factor: 4.530

4.  Developmental Effects of Cannabidiol and Δ9-Tetrahydrocannabinol in Zebrafish.

Authors:  Dennis R Carty; Cammi Thornton; James H Gledhill; Kristine L Willett
Journal:  Toxicol Sci       Date:  2018-03-01       Impact factor: 4.849

5.  Multigenerational consequences of early-life cannabinoid exposure in zebrafish.

Authors:  Dennis R Carty; Zachary S Miller; Cammi Thornton; Zacharias Pandelides; Marisa L Kutchma; Kristine L Willett
Journal:  Toxicol Appl Pharmacol       Date:  2018-12-27       Impact factor: 4.219

6.  Modafinil decreases anxiety-like behaviour in zebrafish.

Authors:  Adrian Johnson; Trevor James Hamilton
Journal:  PeerJ       Date:  2017-02-14       Impact factor: 2.984

7.  The endocannabinoid gene faah2a modulates stress-associated behavior in zebrafish.

Authors:  Randall G Krug; Han B Lee; Louis Y El Khoury; Ashley N Sigafoos; Morgan O Petersen; Karl J Clark
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

8.  Fingerprinting of psychoactive drugs in zebrafish anxiety-like behaviors.

Authors:  Caio Maximino; Annanda Waneza Batista da Silva; Juliana Araújo; Monica Gomes Lima; Vanessa Miranda; Bruna Puty; Rancés Benzecry; Domingos Luiz Wanderley Picanço-Diniz; Amauri Gouveia; Karen Renata Matos Oliveira; Anderson Manoel Herculano
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

Review 9.  Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish.

Authors:  Giancarlo Bruni; Parth Lakhani; David Kokel
Journal:  Front Pharmacol       Date:  2014-07-24       Impact factor: 5.810

10.  Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.

Authors:  Junran Xie; Dongju Xiao; Yun Xu; Jinning Zhao; Li Jiang; Xuming Hu; Yaping Zhang; Lina Yu
Journal:  Oncotarget       Date:  2016-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.